TABLE 2.
Second meal effect studies.
Design* | Subjects‡ | Intervention products* | Study procedure | Outcomes (data analysis)* | Results Mean ± SEM, unless otherwise stated |
|
Sandberg et al. (50) | Cross-over, randomized, two test meals | 38 (30 f/8 m), age 63.9 ± 5.5 year, BMI 24.2 ± 2.5 kg/m2, fasting glucose 5.7 ± 0.4 mmol/l, no known metabolic disease, non-smoking. | Rye bread with added resistant starch (RBRS):43% rye kernels, 43% whole grain rye flour 14% Hi-Maze flour (60% resistant starch type 2, 40% digestible starch). White wheat bread (WWB): 100% refined wheat flour. Composition rye bread/wheat bread (g/portion): portion size 239/171, starch 89/76 (available starch 75/75), insoluble DF 21/4, soluble DF 6/1. |
Subjects consumed one portion of test bread per day for three days before visiting the clinic. On day 1 and 2 bread was divided over the day, on day 3 the portion was consumed at 9 pm. At the clinic subjects consumed 114 g WWB 50 g available starch with 2 dl water after an overnight fast (from 9 pm). Blood was taken at 0, 15, 30, 45, 60, 90, 120, and 180 min. |
Glucose (capillary blood), insulin (venous blood). iAUC0–30, iAUC0–120, incremental peak, Composite Insulin Sensitivity Index (ISIcomposite), HOMA-IR. |
Glucose: iAUC0–30 lower following RBRS, compared to WWB (−14%, p < 0.05). Insulin: Incremental peak lower following RBRS, compared to WWB (−15%, p < 0.01). ISIcomposite higher following RBRS, compared to WWB (+11%, p < 0.05). |
Sandberg et al. (51) | Cross-over, randomized, three test meals | 21 (10 m/11 f), age 25.3 ± 3.9 year, BMI 22.7 ± 2.3 kg/m2, no known metabolic disease, non-smoking. | Whole grain rye flour bread (RFB): 100% whole grain rye flour. Whole grain rye flour and rye kernel bread (RKB): 50% whole grain rye flour, 50% rye kernels White wheat bread (WWB; reference): 100% refined wheat flour. Composition of RFB/RKB/WWB (g/portion): portion size 187/184/122, starch 53/57/52 (available starch 50/50/50, RS 3/7/1), insoluble NSP 11/13/2, soluble NSP 4/4/1, total DF 18/23/4. |
Subjects consumed test breads at 9 pm the night before visiting the clinic. At the clinic subjects consumed one portion WWB with 2 dl water after an overnight fast (from 9 pm). Capillary blood taken at 0, 15, 30, 60, 90, 120, 150, and 180. |
Glucose (all timepoints), insulin (all timepoints except 15 min) iAUC0–120, incremental peak. |
No difference |
Sandberg et al. (49) | Cross-over, randomized, four test meals (2 × 2 factorial design) | 19 (9 m/10 f), age 21.9 ± 1.87 year, BMI 25.6 ± 3.5 kg/m2, no known metabolic disorders, non-smoking. | White wheat bread (WWB; reference): 85% rye kernels and 15% white wheat flour (of cereal dry matter). 121.4 g bread/portion. Rye kernel bread (RKB): 100% white wheat flour. Composition WWB/RKB [g/portion (142.5 g)]: starch 51.3/53.9 (available starch 50/50, resistant starch 1.3/4.9), insoluble NSP 1.5/9.0, soluble NSP 1.1/2.8, DF 3.9/15.6. |
Subjects consumed one portion of test bread with water at 9:30 pm either: the day before visiting the clinic (WWB-1D or RKB-1D) of for three consecutive days before visiting the clinic (WWB-3D or RKB-3D). At the clinical visit the subjects consumed 121.4 g WWB with 2 dl water after an overnight fast (from 9:30 pm). Venous blood drawn at 0, 15, 30, 45, 60, 90, 120, and 180 min. |
Glucose (all timepoints), insulin (all timepoints except 15 min) iAUC0–120, incremental peak, Matsuda index (insulin sensitivity). |
No effect of length of priming (1 or 3 days) were found in any of the outcomes.Glucose: iAUC0–120 and incremental peak was lower following a RKB evening meal than a WWB evening meal (23 and 16%, respectively, p < 0.01). Insulin: iAUC0–120 was lower following a RKB evening meal than a WWB evening meal (13%, p < 0.05) |
‡Data is mean ± sd or (range). *Only test meals and outcomes of interest for investigating the rye factor (insulin, glucose) is included in the table. Abbreviations: BMI, body mass index; DF, dietary fiber; f, female; HOMA-IR, homeostatic model assessment for insulin resistance; iAUC, incremental area under the curve; m, male; and NSP, non-starch polysaccharides.